山东威高集团医用高分子制品股份有限公司（01066）于2026年2月11日发布翌日披露报表，公告显示公司当日于香港联交所回购120,000股H股，占公司现有已发行股本约0.0027%。本次回购每股价格介乎每股5.30港元至5.32港元，总耗资约637,200港元。
回购完成后，公司已发行股份总数为4,481,202,324股，库藏股增至41,130,000股。公司此前于2025年5月27日通过股份回购授权，可购回最多451,560,392股。截至目前，公司已根据该授权累计回购34,481,600股。公司同时确认已遵守所有适用的上市规则及相关法例程序。
据公告显示，本次公告由公司秘书黄妙玲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.